23.03.2013 Views

White Guide and Orange Guide Formatting Project - Pfizer

White Guide and Orange Guide Formatting Project - Pfizer

White Guide and Orange Guide Formatting Project - Pfizer

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

During the meeting:<br />

After the meeting:<br />

Stick to the agenda.<br />

<strong>Orange</strong> <strong>Guide</strong> – Chapter 12: Contracting<br />

Firewall discussions into appropriate segments. One possibility is to separate all discussions<br />

where <strong>Pfizer</strong> or Greenstone are purchasing goods or services (<strong>Pfizer</strong> or Greenstone as<br />

"customer") from those where <strong>Pfizer</strong> or Greenstone are providing discounts, goods or<br />

services (<strong>Pfizer</strong> or Greenstone as "seller").<br />

Manage the other side’s attempts to link discussions of multiple projects by deferring the<br />

issue for future conversation or delegating the issue to colleagues not in attendance.<br />

Carefully approach discussions of non-contracting business opportunities during the<br />

negotiation period prior to <strong>and</strong> around the time of rebate contract expiration.<br />

Evaluate the contracting offer <strong>and</strong> other business proposals independently <strong>and</strong> on their own<br />

merits; separate business teams within <strong>Pfizer</strong> or Greenstone should do the respective<br />

evaluations.<br />

Be mindful of how financial <strong>and</strong> other notes regarding the contracting offer <strong>and</strong> other<br />

business opportunities may appear in hindsight. For example, the valuations for each<br />

business opportunity on the same worksheet may imply that the opportunities are<br />

connected <strong>and</strong> interdependent when the intent was otherwise.<br />

“Swapping” Discounts between Commercial <strong>and</strong> Part D Plans<br />

Many managed care organizations, including HMOs, currently manage both commercial <strong>and</strong> Medicare<br />

Part D books of business. These organizations will negotiate discounts from pharmaceutical<br />

companies on behalf of the government under Medicare Part D, as well as on behalf of their<br />

commercial business. The government has expressed concern that entities will utilize Medicare Part D<br />

leverage to obtain preferential discounts for their commercial books of business.<br />

208<br />

Rev. 09/12<br />

Page 5 of 8

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!